Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sodium-dependent noradrenaline transporter (Homo sapiens (Human)) | BDBM218671 (US9289400, ES609) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 293 | n/a | n/a | n/a | n/a | n/a | n/a |
Drexel University; Rutgers, The State University of New Jersey US Patent | Assay Description Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity. | US Patent US9289400 (2016) BindingDB Entry DOI: 10.7270/Q29S1PWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium-dependent noradrenaline transporter (Homo sapiens (Human)) | BDBM218672 (US9289400, PBZI) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 860 | n/a | n/a | n/a | n/a | n/a | n/a |
Drexel University; Rutgers, The State University of New Jersey US Patent | Assay Description Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity. | US Patent US9289400 (2016) BindingDB Entry DOI: 10.7270/Q29S1PWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium-dependent dopamine transporter (Homo sapiens (Human)) | BDBM218672 (US9289400, PBZI) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 1.61E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Drexel University; Rutgers, The State University of New Jersey US Patent | Assay Description Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity. | US Patent US9289400 (2016) BindingDB Entry DOI: 10.7270/Q29S1PWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium-dependent dopamine transporter (Homo sapiens (Human)) | BDBM218671 (US9289400, ES609) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 8.52E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Drexel University; Rutgers, The State University of New Jersey US Patent | Assay Description Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity. | US Patent US9289400 (2016) BindingDB Entry DOI: 10.7270/Q29S1PWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium-dependent serotonin transporter (Homo sapiens (Human)) | BDBM218672 (US9289400, PBZI) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 1.38E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Drexel University; Rutgers, The State University of New Jersey US Patent | Assay Description Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity. | US Patent US9289400 (2016) BindingDB Entry DOI: 10.7270/Q29S1PWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium-dependent serotonin transporter (Homo sapiens (Human)) | BDBM218671 (US9289400, ES609) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 3.59E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Drexel University; Rutgers, The State University of New Jersey US Patent | Assay Description Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity. | US Patent US9289400 (2016) BindingDB Entry DOI: 10.7270/Q29S1PWN | |||||||||||
More data for this Ligand-Target Pair |